Functional cloning of the miltefosine transporter. A novel P-type phospholipid translocase from Leishmania involved in drug resistance
- PMID: 14514670
- DOI: 10.1074/jbc.M308352200
Functional cloning of the miltefosine transporter. A novel P-type phospholipid translocase from Leishmania involved in drug resistance
Abstract
The antitumor drug miltefosine (hexadecylphosphocholine, MIL) has recently been approved as the first oral agent for the treatment of visceral leishmaniasis. Little is known about the mechanisms of action and uptake of MIL in either parasites or tumor cell lines. We have cloned a putative MIL transporter (LdMT) by functional rescue, using a Leishmania donovani-resistant line defective in the inward-directed translocation of both MIL and glycerophospholipids. LdMT is a novel P-type ATPase belonging to the partially characterized aminophospholipid translocase subfamily. Resistant parasites transfected with LdMT regain their sensitivity to MIL and edelfosine and the ability to normally take up [14C]MIL and fluorescent-labeled glycerophospholipids. Moreover, LdMT localizes to the plasma membrane, and its overexpression in Leishmania tarentolae, a species non-sensitive to MIL, significantly increases the uptake of [14C]MIL, strongly suggesting that this protein behaves as a true translocase. Finally, both LdMT-resistant alleles encompass single but distinct point mutations, each of which impairs transport function, explaining the resistant phenotype. These results demonstrate biochemically and genetically the direct involvement of LdMT in MIL and phospholipids translocation in Leishmania and describe for the first time a P-type ATPase involved in MIL uptake and potency in eukaryotic cells.
Similar articles
-
Phospholipid translocation and miltefosine potency require both L. donovani miltefosine transporter and the new protein LdRos3 in Leishmania parasites.J Biol Chem. 2006 Aug 18;281(33):23766-75. doi: 10.1074/jbc.M605214200. Epub 2006 Jun 19. J Biol Chem. 2006. PMID: 16785229
-
Inactivation of the miltefosine transporter, LdMT, causes miltefosine resistance that is conferred to the amastigote stage of Leishmania donovani and persists in vivo.Int J Antimicrob Agents. 2007 Sep;30(3):229-35. doi: 10.1016/j.ijantimicag.2007.05.007. Epub 2007 Jul 12. Int J Antimicrob Agents. 2007. PMID: 17628445
-
Genomic and Molecular Characterization of Miltefosine Resistance in Leishmania infantum Strains with Either Natural or Acquired Resistance through Experimental Selection of Intracellular Amastigotes.PLoS One. 2016 Apr 28;11(4):e0154101. doi: 10.1371/journal.pone.0154101. eCollection 2016. PLoS One. 2016. PMID: 27123924 Free PMC article.
-
Mechanisms of experimental resistance of Leishmania to miltefosine: Implications for clinical use.Drug Resist Updat. 2006 Feb-Apr;9(1-2):26-39. doi: 10.1016/j.drup.2006.04.001. Drug Resist Updat. 2006. PMID: 16814199 Review.
-
Antiprotozoal activities of phospholipid analogues.Mol Biochem Parasitol. 2003 Feb;126(2):165-72. doi: 10.1016/s0166-6851(02)00283-9. Mol Biochem Parasitol. 2003. PMID: 12615315 Review.
Cited by
-
Amphotericin B resistance in Leishmania amazonensis: In vitro and in vivo characterization of a Brazilian clinical isolate.PLoS Negl Trop Dis. 2024 May 20;18(5):e0012175. doi: 10.1371/journal.pntd.0012175. eCollection 2024 May. PLoS Negl Trop Dis. 2024. PMID: 38768213 Free PMC article.
-
ABC transporter inhibition by beauvericin partially overcomes drug resistance in Leishmania tropica.Antimicrob Agents Chemother. 2024 May 2;68(5):e0136823. doi: 10.1128/aac.01368-23. Epub 2024 Apr 4. Antimicrob Agents Chemother. 2024. PMID: 38572959 Free PMC article.
-
Phenotypic screening reveals a highly selective phthalimide-based compound with antileishmanial activity.PLoS Negl Trop Dis. 2024 Mar 25;18(3):e0012050. doi: 10.1371/journal.pntd.0012050. eCollection 2024 Mar. PLoS Negl Trop Dis. 2024. PMID: 38527083 Free PMC article.
-
Further Investigations of Nitroheterocyclic Compounds as Potential Antikinetoplastid Drug Candidates.Biomolecules. 2023 Apr 1;13(4):637. doi: 10.3390/biom13040637. Biomolecules. 2023. PMID: 37189384 Free PMC article. Review.
-
The paradigm of intracellular parasite survival and drug resistance in leishmanial parasite through genome plasticity and epigenetics: Perception and future perspective.Front Cell Infect Microbiol. 2023 Feb 6;13:1001973. doi: 10.3389/fcimb.2023.1001973. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 36814446 Free PMC article. Review.
Publication types
MeSH terms
Substances
Associated data
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources